Michael P Terns (Michael Terns)

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 10

Top Venues

Nucleic acids research

Nature microbiology

RNA (New York, N.Y.)

RNA biology

University of Georgia

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Georgia

United States

Distinguished Research Professor :: Biochemistry and Molecular Biology

Publications

Hemant N Goswami, Fozieh Ahmadizadeh, Bing Wang, Doreen Addo-Yobo, Yu Zhao, A Carl Whittington, Huan He, Michael P Terns, Hong Li
Molecular basis for cA6 synthesis by a type III-A CRISPR-Cas enzyme and its conversion to cA4 production. Nucleic acids research (2024)
Ryan J Catchpole, Valérie Barbe, Ghislaine Magdelenat, Evelyne Marguet, Michael P Terns, Jacques Oberto, Patrick Forterre, Violette Da Cunha
A self-transmissible plasmid from a hyperthermophile that facilitates genetic modification of diverse Archaea. Nature microbiology (2023)
Anna-Louise Reysenbach, Michael P Terns
CRISPR-influenced symbiosis. Nature microbiology (2023)
Elizabeth A Watts, Sandra C Garrett, Ryan J Catchpole, Landon M Clark, Travis J Sanders, Craig J Marshall, Breanna R Wenck, Robert L Vickerman, Thomas J Santangelo, Ryan T Fuchs, Gregory Brett Robb, Sara Olson, Brenton R Graveley, Michael P Terns
Histones direct site-specific CRISPR spacer acquisition in model archaeon. Nature microbiology (2023)
Sandra C Garrett, Cecile Philippe, Jenny G Kim, Yunzhou Wei, Katie A Johnson, Sara Olson, Brenton R Graveley, Michael P Terns
Investigation of CRISPR-Independent Phage Resistance Mechanisms Reveals a Role for FtsH in Phage Adsorption to Streptococcus thermophilus. Journal of bacteriology (2023)
Sagar Sridhara, Jay Rai, Charlisa Whyms, Hemant Goswami, Huan He, Walter Woodside, Michael P Terns, Hong Li
Structural and biochemical characterization of in vivo assembled Lactococcus lactis CRISPR-Csm complex. Communications biology 5 (1) (2022)
Walter T Woodside, Nikita Vantsev, Ryan J Catchpole, Sandra C Garrett, Sara Olson, Brenton R Graveley, Michael P Terns
Type III-A CRISPR systems as a versatile gene knockdown technology. RNA (New York, N.Y.) 28 (8) (2022)
Xinfu Zhang, Sandra Garrett, Brenton R Graveley, Michael P Terns
Unique properties of spacer acquisition by the type III-A CRISPR-Cas system. Nucleic acids research (2021)
Kawanda Foster, Joshua Kalter, Walter Woodside, Rebecca M Terns, Michael P Terns
The ribonuclease activity of Csm6 is required for anti-plasmid immunity by Type III-A CRISPR-Cas systems. RNA biology 16 (4) (2018)
H Travis Ichikawa, John C Cooper, Leja Lo, Jason Potter, Rebecca M Terns, Michael P Terns
Programmable type III-A CRISPR-Cas DNA targeting modules. PloS one 12 (4) (2017)
Daan C Swarts, Jorrit W Hegge, Ismael Hinojo, Masami Shiimori, Michael A Ellis, Justin Dumrongkulraksa, Rebecca M Terns, Michael P Terns, John van der Oost
Argonaute of the archaeon Pyrococcus furiosus is a DNA-guided nuclease that targets cognate DNA. Nucleic acids research 43 (10) (2015)
Joshua Elmore, Trace Deighan, Jan Westpheling, Rebecca M Terns, Michael P Terns
DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus. Nucleic acids research 43 (21) (2015)
Caryn R Hale, Alexis Cocozaki, Hong Li, Rebecca M Terns, Michael P Terns
Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex. Genes & development 28 (21) (2014)

Michael P Terns.css-eqlu8i{font-size:small;padding-left:4px;} (Michael Terns)

Publication Activity (10 Years)

Top Topics

Top Venues

Michael P Terns (Michael Terns)